Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis

Clinical Microbiology and Infection

Volumn 11, Issue 7, 2005, Pages 531-539

  Gryadunov, D A ^a   Mikhailovich, V ^a   Lapa, S ^a   Roudinskii, N ^a   Donnikov, M ^a   Pan'kov, S ^a   Markova, O ^a   Kuz'min, A ^b   Chernousova, L ^b   Skotnikova, O ^c   Moroz, A ^c   Zasedatelev, A ^a   Mirzabekov, A ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

^c Moscow Tuberculosis Control Center   (Russian Federation)

Author keywords

Biochips; Hybridisation; Multidrug resistance; Mycobacterium tuberculosis; Oligonucleotide microarrays; PCR

Indexed keywords

ISONIAZID; OLIGONUCLEOTIDE; POLYACRYLAMIDE GEL; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DRUG SENSITIVITY; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM CULTURE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 21244432743     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01183.x     Document Type: Article

References (31)

1. Heyman SJ, Brewer TF, Wilson ME et al. The need for global action against multidrug-resistant tuberculosis. JAMA 1999; 281: 2138-2140.
2. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 1998; 79: 3-29.
3. Garcia de Viedma D. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin Microbiol Infect 2003; 9: 349-359.
4. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998; 4: 195-209.
5. Telenti A, Honore N, Bernasconi C et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35: 719-723.
6. Tracevska T, Jansone I, Broka L et al. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 2002; 40: 3789-3792.
7. Mokrousov I, Otten T, Vyazovaya A et al. PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. Eur J Clin Microbiol Infect Dis 2003; 22: 342-348.
8. Williams DL, Spring L, Gillis TP et al. Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis 1998; 26: 446-450.
9. Scarpellini P, Braglia, S, Carrera P et al. Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 1999; 43: 2550-2554.
10. Cavusoglu C, Karaca-Derici Y, Bilgic A. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Clin Microbiol Infect 2004; 10: 662-665.
11. Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F et al. New realtime PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 988-995.
12. Torres MJ, Criado A, Palomares JC, Aznar J. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 3194-3199.
13. Piatek AS, Telenti A, Murray MR et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 2000; 44: 103-110.
14. Yue J, Shi W, Xie J et al. Detection of rifampin-resistant Mycobacterium tuberculosis strains by using a specialized oligonucleotide microarray. Diagn Microbiol Infect Dis 2004; 48: 47-54.
15. Troesch A, Nguyen H, Miyada CG et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 1999; 37: 49-55.
16. Sougakoff W, Rodrigue M, Truffot-Pernot C et al. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2004; 10: 289-294.
17. Rossau R, Traore H, De Beenhouwer H et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997; 41: 2093-2098.
18. Drobniewski FA, Watterson SA, Wilson SM et al. A clinical, microbiological and economic analysis of a national UK service for the rapid molecular diagnosis of tuberculosis and rifampin resistance in Mycobacterium tuberculosis. J Med Microbiol 2000; 49: 271-278.
19. Mikhailovich V, Lapa S, Gryadunov D et al. Identification of Mycobacterium tuberculosis strains resistant to rifampin by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol 2001; 39: 2531-2540.
20. Kent PT, Kubica GP. Public health mycobacteriology. A guide for level III laboratory. Atlanta, GA: Centers for Disease Control and Prevention, 1985.
21. Catanzaro A, Perry S, Clarridge JE et al. The role of clinical suspicion in evaluating a new diagnostic test for active tubercuiosis: results of a multicenter prospective trial. JAMA 2000; 283: 639-646.
22. Metchock BG, Nolte FS, Wallace RJ. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 7th edn. Washington, DC: ASM Press, 1999; 399-437.
23. Rubina AY, Pan'kov SV, Dementieva EI et al. Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production. Analyt Biochem 2004; 325: 92-106.
24. Mikheikin AL, Chudinov AV, Iaroshchuk AI et al. Dye with low specificity to nucleotide sequences of DNA: use for assessing the quantity of oligonucleotides, immobilized in cells of biological microchips. Mol Biol (Mosk) 2003; 37: 1061-1070.
25. Mokrousov I, Narvskaya O, Otten T et al. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996-2001. Antimicrob Agents Chemother 2002; 46: 1417-1424.
26. Heep M, Rieger U, Beck D, Lehn N. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 1075-1077.
27. Lee AS, Teo AS, Wong SY. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2001; 45: 2157-2159.
28. Sreevatsan S, Pan X, Zhang Y et al. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother 1997; 41: 600-606.
29. Kelley CL, Rouse DA, Morris SL. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 2057-2058.
30. Van Soolingen D, de Haas PE, Van Doorn HR et al. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands. J Infect Dis 2000; 182: 1788-1790.
31. Marttila HJ, Marjamaki M, Viljanen MK et al. Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 2003; 22: 757-759.